skip to Main Content

News & Media

PRESS RELEASE: Michael Aldridge, Seasoned Biotech Executive, Appointed CEO of Focal Medical | Company Launches Corporate Rebranding

RALEIGH, N.C. (November 1, 2022): Focal Medical, Inc. (formerly Advanced Chemotherapy Technologies, Inc.), a privately held,…

Read more

PRESS RELEASE: Advanced Chemotherapy Technologies, Inc. Announces $2.5M Series A Investment by Spectrum Financial

This investment is in addition to the previously announced Series A investment of $5.5 million…

Read more

PRESS RELEASE: Advanced Chemotherapy Technologies, Inc. Announces $5.5M Series A Financing Round led by Khosla Ventures

The capital will be used to fund initial clinical development of the company’s ACT-IOP-003 local…

Read more

PRESS RELEASE: Advanced Chemotherapy Technologies, Inc. Announces Issuance of US Patent for an Interventional Drug Delivery System

Raleigh, NC, June 30th, 2020 – Advanced Chemotherapy Technologies, Inc. (www.advancedchemotech.com), a combination drug-device company…

Read more

PRESS RELEASE: Advanced Chemotherapy Technologies, Inc. Files IND Application for First in Human use of ACT-IOP-003 in Pancreatic Cancer Patients

Raleigh, NC, March 20th, 2020 – Advanced Chemotherapy Technologies, Inc. (www.advancedchemotech.com), a combination drug-device company…

Read more

PRESS RELEASE: Notice of Allowance Received from U.S. Patent and Trademark Office for Patent Application with Claims Covering Combination Iontophoresis and Radiation Therapy

Raleigh, NC, August 30th, 2019 – Advanced Chemotherapy Technologies, Inc. (www.advancedchemotech.com), a combination drug-device company…

Read more

Leading the way toward greater hope for pancreatic cancer patients

Tony Voiers joined Advanced Chemotherapy Technologies as CEO after meeting with company co-founder Jen Jen…

Read more

NC companies shine at SEBIO Forum

November 18, 2018— Bioscience companies from North Carolina dominated the awards competition at the 20th…

Read more

Simulation Optimizes a Chemotherapy Implant to Treat Pancreatic Cancer

There are few illnesses as crafty as pancreatic cancer. It spreads like weeds and resists…

Read more

ACT announces receipt of NIH grant to support first in human clinical trial development and execution for an implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma.

Raleigh, NC, September 28th, 2018 – Advanced Chemotherapy Technologies, Inc. (www.advancedchemotech.com), a combination drug-device company…

Read more

‘In MedTech History’ – Oncology Device Technology

Fueled by the passion of pioneering physicists, physicians and medtech innovators looking for a way…

Read more

UNC Spinout Developing Device for Better Chemo Delivery

Pancreatic cancer is an elusive and deadly disease. It often has no initial symptoms, and…

Read more
Stay up to date
Follow us

Focal Medical, Inc.
111 James Jackson Ave. Suite 131
Cary, NC 27513

Focal Medical Copyright 2022 | Focal Medical is an equal opportunity employer
Terms of servicePrivacy policyOther policies 

Back To Top